Related Experiment Video
Updated: Sep 5, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
WNK1 in Malignant Behaviors: A Potential Target for Cancer?
Ji-Ung Jung1, Ankita B Jaykumar1, Melanie H Cobb1
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States.
Abstract:
Metastasis is the major cause of mortality in cancer patients. Analyses of mouse models and patient data have implicated the protein kinase WNK1 as one of a handful of genes uniquely linked to a subset of invasive cancers. WNK1 signaling pathways are widely implicated in the regulation of ion co-transporters and in controlling cell responses to osmotic stress. In this review we will discuss its actions in tumor malignancy in human cancers and present evidence for its function in invasion, migration, angiogenesis and mesenchymal transition.
Insights
The protein kinase WNK1 is linked to invasive cancers and metastasis. This review explores WNK1
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Metastasis is a leading cause of cancer mortality.
- The protein kinase WNK1 is implicated in a subset of invasive cancers.
- WNK1 signaling regulates ion transporters and osmotic stress responses.
Purpose of the Study:
- To review the role of WNK1 in human cancer malignancy.
- To present evidence for WNK1's function in tumor invasion and metastasis.
- To discuss WNK1's involvement in angiogenesis and epithelial-mesenchymal transition.
Main Methods:
- Literature review of studies on WNK1 in cancer.
- Analysis of mouse models and patient data.
- Examination of WNK1 signaling pathways.
Main Results:
- WNK1 is uniquely linked to invasive cancers.
- WNK1 signaling is involved in regulating cell movement and blood vessel formation.
- Evidence suggests WNK1 promotes tumor cell invasion and metastasis.
Conclusions:
- WNK1 plays a significant role in tumor malignancy.
- Targeting WNK1 may offer therapeutic strategies for invasive cancers.
- Further research into WNK1's mechanisms is warranted.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Canonical Wnt Signaling Pathway
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...